Literature DB >> 15841690

Advances in laboratory testing for HIV.

Elizabeth M Dax1, Alicia Arnott.   

Abstract

In 2004, the diagnosis of established human immunodeficiency virus (HIV) infection can be made with close to 100% assurity. The extraordinarily engineered performances of HIV-screening assays are unprecedented. The well-established confirmatory tests performed by well-versed laboratories using criteria that are well understood in order to interpret the results of these tests give highly accurate outcomes of diagnostic testing strategies. Furthermore, the ability to monitor the progress of the infection and the viral pathogenesis is possible through the use of tests that quantify viral load or the peripheral CD4+ T-cells and other lymphocyte sub-type levels. Newer laboratory testing mechanisms, such as assessment of reverse transcriptase activity and sophisticated cell staining and flow cytometric analyses, have been used to map disease processes and progress on a research level and may be used in future to fine-tune therapy and to follow disease progression in even greater detail. Regulation of all HIV tests is of the highest level in Australia. In-house tests will be expected to conform to the levels specified for commercially produced tests.

Entities:  

Mesh:

Year:  2004        PMID: 15841690     DOI: 10.1080/00313020400010922

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

Review 1.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

2.  Perspectives on medical research involving men in schizophrenia and HIV-related protocols.

Authors:  Laura Weiss Roberts; Teddy D Warner; Katherine A Green Hammond; Cynthia M A Geppert
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

3.  Evaluation of an external quality assessment program for HIV testing in Haiti, 2006-2011.

Authors:  Frantz Jean Louis; Renette Anselme; Clement Ndongmo; Josiane Buteau; Jacques Boncy; Georges Dahourou; John Vertefeuille; Barbara Marston; S Arunmozhi Balajee
Journal:  Am J Clin Pathol       Date:  2013-12       Impact factor: 2.493

4.  Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, Zimbabwe.

Authors:  Kerina Duri; Fredrik Müller; Felicity Z Gumbo; Nyaradzai E Kurewa; Simba Rusakaniko; Mike Z Chirenje; Munyaradzi P Mapingure; Babill Stray-Pedersen
Journal:  BMC Infect Dis       Date:  2011-01-06       Impact factor: 3.090

5.  Western Blot-Based Logistic Regression Model for the Identification of Recent HIV-1 Infection: A Promising HIV-1 Surveillance Approach for Resource-Limited Regions.

Authors:  Jiegang Huang; Minlian Wang; Chunyuan Huang; Bingyu Liang; Junjun Jiang; Chuanyi Ning; Ning Zang; Hui Chen; Jie Liu; Rongfeng Chen; Yanyan Liao; Li Ye; Hao Liang
Journal:  Biomed Res Int       Date:  2018-01-14       Impact factor: 3.411

6.  Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain.

Authors:  Christian Drosten; Marcus Panning; Jan Felix Drexler; Florian Hänsel; Celia Pedroso; Jane Yeats; Luciano Kleber de Souza Luna; Matthew Samuel; Britta Liedigk; Ute Lippert; Martin Stürmer; Hans Wilhelm Doerr; Carlos Brites; Wolfgang Preiser
Journal:  Clin Chem       Date:  2006-04-20       Impact factor: 8.327

7.  Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing.

Authors:  Kate M Learmonth; Dale A McPhee; Darren K Jardine; Sandy K Walker; Thein-Thein Aye; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.